From: Osteocalcin and serum insulin-like growth factor-1 as biochemical skeletal maturity indicators
Serum IGF-1 | Osteocalcin | ||||||||
---|---|---|---|---|---|---|---|---|---|
Kruskal-Wallis test on serum IGF-1 vs CVMI is significant: P < 0.0001 | Kruskal-Wallis test on osteocalcin vs CVMI is significant: P < 0.0001 | ||||||||
Mann-Whitney U tests comparing the mean ranks of serum IGF-1 for CVMI stage a vs b | Mann-Whitney U tests comparing the mean ranks of osteocalcin for CVMI stage a vs b | ||||||||
CVMI stage a | CVMI stage b | Difference in location (mean): a-b | P value | Difference in location (mean): a-b | P value | ||||
Males | Females | Males | Females | Males | Females | Males | Females | ||
1 | 2 | −56.00 | −31.57 | 0.114 (NS) | 0.0001 | −0.51 | −1.12 | 0.273 (NS) | 0.175 (NS) |
3 | −144.82 | −351.68 | 0.011 | 0.0001 | −2.30 | −2.22 | 0.277 (NS) | 0.237 (NS) | |
4 | −288.24 | −332.07 | 0.001 | 0.0001 | −2.83 | −1.99 | 0.007 | 0.064 (NS) | |
5 | −144.37 | −206.93 | 0.014 | 0.0001 | −3.65 | 0.03 | 0.013 | 0.707 (NS) | |
6 | −72.81 | −29.99 | 0.114 (NS) | 0.0001 | 0.36 | 0.98 | 0.273 (NS) | 0.043 | |
2 | 3 | −88.82 | −320.11 | 0.225 (NS) | 0.0001 | −1.79 | −1.10 | 0.663 (NS) | 0.959 (NS) |
4 | −232.24 | −300.50 | 0.0001 | 0.0001 | −2.32 | −0.87 | 0.031 | 0.463 (NS) | |
5 | −88.37 | −175.36 | 0.291 (NS) | 0.0001 | −3.14 | 1.15 | 0.043 | 0.094 (NS) | |
6 | −16.81 | 1.57 | 0.514 (NS) | 0.713(NS) | 0.87 | 2.10 | 0.065 (NS) | 0.004 | |
3 | 4 | −143.42 | 19.61 | 0.008 | 0.867(NS) | −0.53 | 0.23 | 0.382 (NS) | 0.662 (NS) |
5 | 0.44 | 144.75 | 0.852 (NS) | 0.0001 | −1.35 | 2.25 | 0.231 (NS) | 0.157 (NS) | |
6 | 72.01 | 321.68 | 0.347 (NS) | 0.0001 | 2.66 | 3.20 | 0.044 | 0.006 | |
4 | 5 | 143.86 | 125.13 | 0.011 | 0.019 | −0.82 | 2.02 | 0.554 (NS) | 0.053 (NS) |
6 | 215.43 | 302.07 | 0.0001 | 0.0001 | 3.19 | 2.97 | 0.002 | 0.001 | |
5 | 6 | 71.56 | 176.93 | 0.319 (NS) | 0.0001 | 4.01 | 0.95 | 0.002 | 0.053 (NS) |